Device Trial Radar · NCT04829461
Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible Cystoscopy
Last checked: Nov 20, 2026Latest source record: Jun 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
102
Actual
Start
Apr 27, 2021
Primary completion
Jul 15, 2022
Study completion Jul 20, 2022
Sponsor
- Lead sponsor
- Ambu Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Ambu A/S
- First posted
- Apr 2, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the use of the single-use Ambu® aScope™ 4 Cysto for removal of ureteral stents as compared to routine flexible reusable cystoscopes.
Conditions
- Cystoscopy
- Ureteral Stent
Interventions
Ambu® aScope™ 4 Cysto with the aView™ 2 Advance used for stent removalDevice
Procedure using a single-use cystoscope for stent removal
Standard of care reusable cystoscope used for stent removalDevice
Procedure using a reusable cystoscope for stent removal
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Successful Stent RemovalTime frame: Procedure Date (Day 0)
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
The Pennsylvania State University and The Milton S. Hershey Medical Center
Hershey, Pennsylvania
University of Texas Southwestern Medical Center
Dallas, Texas
University of Wisconsin-Madison
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.